LINC00641
gene geneOn this page
Summary
LINC00641 (long intergenic non-protein coding RNA 641, HGNC:27511) is a long non-coding RNA gene on chromosome 14q11.2.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27511 |
| Approved symbol | LINC00641 |
| Name | long intergenic non-protein coding RNA 641 |
| Location | 14q11.2 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000258441 |
| Ensembl biotype | lncRNA |
| Entrez | 283624 |
| RNAcentral | URS000075E871 — lncRNA, 5439 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 retained_intron, 1 lncRNA
ENST00000555379, ENST00000555688
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000555379 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002483429 | 21200079 | 21205503 |
Expression profiles
Bgee: expression breadth ubiquitous, 167 present calls, max score 95.33.
Top tissues by expression
246 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 95.33 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 94.51 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 93.83 | gold quality |
| cerebellar cortex | UBERON:0002129 | 93.76 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 93.53 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 92.81 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 92.54 | gold quality |
| right frontal lobe | UBERON:0002810 | 91.76 | gold quality |
| prefrontal cortex | UBERON:0000451 | 90.57 | gold quality |
| hypothalamus | UBERON:0001898 | 90.48 | gold quality |
| cerebellum | UBERON:0002037 | 90.19 | gold quality |
| ganglionic eminence | UBERON:0004023 | 89.84 | gold quality |
| amygdala | UBERON:0001876 | 89.75 | gold quality |
| nucleus accumbens | UBERON:0001882 | 89.27 | gold quality |
| putamen | UBERON:0001874 | 89.24 | gold quality |
| caudate nucleus | UBERON:0001873 | 88.70 | gold quality |
| spinal cord | UBERON:0002240 | 88.12 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 86.77 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.20 | gold quality |
| neocortex | UBERON:0001950 | 84.98 | gold quality |
| tibial nerve | UBERON:0001323 | 84.93 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 84.53 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 84.52 | gold quality |
| lower esophagus | UBERON:0013473 | 84.50 | gold quality |
| tibial artery | UBERON:0007610 | 84.35 | gold quality |
| popliteal artery | UBERON:0002250 | 84.32 | gold quality |
| mucosa of stomach | UBERON:0001199 | 84.14 | gold quality |
| left uterine tube | UBERON:0001303 | 84.14 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 84.01 | gold quality |
| frontal cortex | UBERON:0001870 | 83.65 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.98 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 14)
- study illustrated a novel signaling cascade of LINC00641/miR-197-3p/KLF10/PTEN/PI3K/AKT pathway regulating bladder cancer development (PMID:30060954)
- LINC00641 targets miR-153-3p, and thus affects ATG5 expression, and autophagic cell death in intervertebral disc degeneration. (PMID:30378116)
- LINC00641 suppressed cell proliferation and induced cell apoptosis in NSCLC, indicating that LINC00641 exerted tumor-suppressive role in NSCLC. Through mechanism investigation, we determined that LINC00641 acted as a competing endogenous RNA (ceRNA) in NSCLC by sponging miR-424-5p to upregulate phospholipid scramblase (PLSCR4) expression. (PMID:31322545)
- Long intergenic noncoding RNA 00641 inhibits breast cancer cell proliferation, migration, and invasion by sponging miR-194-5p. (PMID:31490021)
- Long non-coding RNA LINC00641 promotes cell growth and migration through modulating miR-378a/ZBTB20 axis in acute myeloid leukemia. (PMID:31539138)
- LINC00641 hinders the progression of cervical cancer by targeting miR-378a-3p/CPEB3. (PMID:32367630)
- LINC00641/miR-582-5p mediate oxaliplatin resistance by activating autophagy in gastric adenocarcinoma. (PMID:32917936)
- LINC00641 regulates prostate cancer cell growth and apoptosis via the miR-365a-3p/VGLL4 axis. (PMID:33506898)
- LINC00641 induces the malignant progression of colorectal carcinoma through the miRNA-424-5p/PLSCR4 feedback loop. (PMID:33577029)
- Linc00641 promotes the progression of gastric carcinoma by modulating the miR-429/Notch-1 axis. (PMID:33714199)
- LINC00641 Inhibits the Development of Cutaneous Squamous Cell Carcinoma By Downregulating miR-424 in A431 Cells. (PMID:33885353)
- LINC00641 contributes to nasopharyngeal carcinoma cell malignancy through FOXD1 upregulation at the post-transcriptional level. (PMID:34767742)
- Long non-coding RNA long intergenic non-coding 00641 mediates cell progression with stimulating cisplatin-resistance in osteosarcoma cells via microRNA-320d/myeloid cell leukemia-1 axis. (PMID:35266447)
- Prognostic utility of lncRNAs (LINC00565 and LINC00641) as molecular markers in glioblastoma multiforme (GBM). (PMID:35668225)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.